Johnson & Johnson Proposes $5.5 Billion Settlement for Remaining Talc Lawsuits
Johnson & Johnson has proposed a $5.5 billion settlement to resolve remaining lawsuits alleging that its talc products caused ovarian cancer. The settlement requires at least 95% of claimants to participate. This move comes after a previous $9 billion settlement…
Cleveland Akron, OH, July 28, 2026 —
Johnson & Johnson has put forth a proposal for a $5.5 billion settlement aimed at resolving the remaining lawsuits that allege its talc products led to ovarian cancer. The terms of this proposed settlement stipulate that a minimum of 95% of all eligible claimants must agree to participate for the deal to move forward.
This latest settlement offer follows a previous attempt by the company to settle these claims. A prior $9 billion settlement was ultimately denied, leading to continued legal proceedings. In subsequent legal battles, plaintiffs have faced difficulties in presenting direct evidence to establish a definitive link between Johnson & Johnson’s talc products and the development of cancer.
The company has been involved in numerous lawsuits concerning its talc-based powders, with plaintiffs claiming that the use of these products resulted in ovarian cancer. The proposed $5.5 billion settlement represents a significant financial commitment by Johnson & Johnson as it seeks to bring an end to this protracted legal chapter. The requirement for 95% claimant participation underscores the company’s intention to achieve a broad resolution.
The legal challenges have highlighted the complexities of proving causation in product liability cases, particularly when dealing with long-term health issues. The outcome of this proposed settlement will depend on the claimants’ collective decision to accept the terms offered by Johnson & Johnson.
Story summarized from the original created by AP via Scripps News Group on www.news5cleveland.com, see more information here.
